[abstract] A 10-YEAR RETROSPECTIVE STUDY OF THE EFFECTIVENESS OF HYPERBARIC OXYGEN THERAPY IN TREATING CRITICALLY ILL PEDIATRIC PATIENTS.

Rubicon Research Repository/Manakin Repository

[abstract] A 10-YEAR RETROSPECTIVE STUDY OF THE EFFECTIVENESS OF HYPERBARIC OXYGEN THERAPY IN TREATING CRITICALLY ILL PEDIATRIC PATIENTS.

Show full item record


Title: [abstract] A 10-YEAR RETROSPECTIVE STUDY OF THE EFFECTIVENESS OF HYPERBARIC OXYGEN THERAPY IN TREATING CRITICALLY ILL PEDIATRIC PATIENTS.
Author: Yu, T; Poon, C; Moore, P; Terry, M; Gold, P; Lo, T
Abstract: BACKGROUND & AIMS: Hyperbaric oxygen therapy (HBOT) is effective in treating numerous medical conditions including: air embolism, decompression illness, carbon monoxide poisoning, problem wounds and refractory osteomyelitis. No study has explicitly examined the effective use of HBOT in healing critically ill pediatric patients with indication for HBOT. METHODS: A retrospective chart review of patients treated with HBOT from 1995-2004 in our monoplace chambers was conducted. Our operation is entirely supervised by critical care/pulmonary medicine physicians and performed by licensed respiratory care practitioners and critical care nurses. RESULTS: Seventy-two critically ill pediatric patients were treated with HBOT. Forty-eight (67%) of the patients were male, 24 (33%) were female. Their ages ranged from 15 days to 17 years (mean age: 10 years). HBOT diagnoses included: compromised flaps/grafts (27), refractory osteomyelitis (8), acute traumatic ischemia (7), carbon monoxide poisoning (7), problem wound (7), mucormycosis (5), necrotizing faciitis (6), soft tissue radiation necrosis (2), crush injury (1), mixed soft tissue infection (1) and osteoradionecrosis (1). Critical care devices present or procedures associated with HBOT included: intravenous lines (50), arterial lines (15), ventilators (13), vasopressors (4) and non-invasive blood pressure monitors (2). Side effects associated with the treatments included need for surgical placement of pressure equalizing ear tubes (3), bilateral serous otitis media (1), ear pain (1) and vomiting (1). 60% of patients were successfully treated with HBOT. No deaths were associated with any of the treatments given. CONCLUSIONS: HBOT is an effective treatment for critically ill pediatric patients in the appropriate environment. It was associated with few side effects and no mortality in our patient population.
Description: Abstract of the Undersea & Hyperbaric Medical Society 2008 Annual Scientific Meeting June 26-28, 2008 Salt Lake City Marriott Downtown, Salt Lake City, Utah.
URI: http://archive.rubicon-foundation.org/7841
Date: 2008

Files in this item

Files Size Format View
abstract.txt 193bytes Text file View/Open

This item appears in the following Collection(s)

  • UHMS Meeting Abstracts
    This is a collection of the published abstracts from the Undersea and Hyperbaric Medical Society (UHMS) annual meetings.

Show full item record

Browse

My Account